Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Steven J Feigenberg

Showing results (91-100 of 117) with videos related to

Pageof 12
Sort By:
Clinical Lung Cancer|December 6, 2020
Outcomes in Patients With Non-small-cell Lung Cancer With Brain Metastases Treated With Pembrolizumab-based TherapyLova Sun, Christiana W Davis, Wei-Ting Hwang, et al.
Clinical Lung Cancer|October 9, 2023
Patterns of Failure in Metastatic NSCLC Treated With First Line Pembrolizumab and Use of Local Therapy in Patients With OligoprogressionCole Friedes, Nikhil Yegya-Raman, Siqi Zhang, et al.
Advances in Radiation Oncology|July 6, 2023
Cardiovascular Substructure Dose and Cardiac Events following Proton- and Photon-Based Chemoradiotherapy for Non-Small Cell Lung CancerJyotsna Natarajan, Nikhil Yegya-Raman, Timothy P Kegelman, et al.
International Journal of Radiation Oncology, Biology, Physics|October 22, 2023
Patterns of Failure, Low-Volume Relapse, and Subsequent Ablative Management in Locally Advanced Non-Small Cell Lung Cancer Treated With Definitive Chemoradiation and Consolidation Immune Checkpoint InhibitorsCole Friedes, Michelle Iocolano, Sang Ho Lee, et al.
International Journal of Radiation Oncology, Biology, Physics|October 27, 2019
Early Tumor and Nodal Response in Patients with Locally Advanced Non-Small Cell Lung Carcinoma Predict for Oncologic Outcomes in Patients Treated with Concurrent Proton Therapy and ChemotherapyAmardeep S Grewal, Eun Jeong Min, Qi Long, et al.
Lung Cancer (Amsterdam, Netherlands)|November 28, 2017
Clinical outcomes of black vs. non-black patients with locally advanced non-small cell lung cancerMelissa A L Vyfhuis, Neha Bhooshan, Jason Molitoris, et al.
Lung Cancer (Amsterdam, Netherlands)|January 1, 2018
Corrigendum to "Clinical outcomes of black vs. non-black patients with locally advanced non-small cell lung cancer" [Lung Cancer 114, (December 2017) 44-49]Melissa A L Vyfhuis, Neha Bhooshan, Jason Molitoris, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|June 21, 2017
Randomized Phase II Study of Preoperative Chemoradiotherapy ± Panitumumab Followed by Consolidation Chemotherapy in Potentially Operable Locally Advanced (Stage IIIa, N2+) Non-Small Cell Lung Cancer: NRG Oncology RTOG 0839Martin J Edelman, Chen Hu, Quynh-Thu Le, et al.
International Journal of Radiation Oncology, Biology, Physics|February 16, 2024
FLASH Proton Radiation Therapy Mitigates Inflammatory and Fibrotic Pathways and Preserves Cardiac Function in a Preclinical Mouse Model of Radiation-Induced Heart DiseaseKyle Kim, Michele M Kim, Giorgos Skoufos, et al.
American Journal of Clinical Oncology|November 6, 2025
Real World Radiographic Response Rates and Preoperative Attrition in Patients With Non-Small Cell Lung Cancer (NSCLC) Treated With Neoadjuvant ChemoimmunotherapyCole Friedes, Michelle Iocolano, Nikhil Yegya-Raman, et al.
Pageof 12

Showing results (91-100 of 117) with videos related to

Sort By:
Pageof 12
Clinical Lung Cancer|December 6, 2020
Outcomes in Patients With Non-small-cell Lung Cancer With Brain Metastases Treated With Pembrolizumab-based TherapyLova Sun, Christiana W Davis, Wei-Ting Hwang, et al.
Clinical Lung Cancer|October 9, 2023
Patterns of Failure in Metastatic NSCLC Treated With First Line Pembrolizumab and Use of Local Therapy in Patients With OligoprogressionCole Friedes, Nikhil Yegya-Raman, Siqi Zhang, et al.
Advances in Radiation Oncology|July 6, 2023
Cardiovascular Substructure Dose and Cardiac Events following Proton- and Photon-Based Chemoradiotherapy for Non-Small Cell Lung CancerJyotsna Natarajan, Nikhil Yegya-Raman, Timothy P Kegelman, et al.
International Journal of Radiation Oncology, Biology, Physics|October 22, 2023
Patterns of Failure, Low-Volume Relapse, and Subsequent Ablative Management in Locally Advanced Non-Small Cell Lung Cancer Treated With Definitive Chemoradiation and Consolidation Immune Checkpoint InhibitorsCole Friedes, Michelle Iocolano, Sang Ho Lee, et al.
International Journal of Radiation Oncology, Biology, Physics|October 27, 2019
Early Tumor and Nodal Response in Patients with Locally Advanced Non-Small Cell Lung Carcinoma Predict for Oncologic Outcomes in Patients Treated with Concurrent Proton Therapy and ChemotherapyAmardeep S Grewal, Eun Jeong Min, Qi Long, et al.
Lung Cancer (Amsterdam, Netherlands)|November 28, 2017
Clinical outcomes of black vs. non-black patients with locally advanced non-small cell lung cancerMelissa A L Vyfhuis, Neha Bhooshan, Jason Molitoris, et al.
Lung Cancer (Amsterdam, Netherlands)|January 1, 2018
Corrigendum to "Clinical outcomes of black vs. non-black patients with locally advanced non-small cell lung cancer" [Lung Cancer 114, (December 2017) 44-49]Melissa A L Vyfhuis, Neha Bhooshan, Jason Molitoris, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|June 21, 2017
Randomized Phase II Study of Preoperative Chemoradiotherapy ± Panitumumab Followed by Consolidation Chemotherapy in Potentially Operable Locally Advanced (Stage IIIa, N2+) Non-Small Cell Lung Cancer: NRG Oncology RTOG 0839Martin J Edelman, Chen Hu, Quynh-Thu Le, et al.
International Journal of Radiation Oncology, Biology, Physics|February 16, 2024
FLASH Proton Radiation Therapy Mitigates Inflammatory and Fibrotic Pathways and Preserves Cardiac Function in a Preclinical Mouse Model of Radiation-Induced Heart DiseaseKyle Kim, Michele M Kim, Giorgos Skoufos, et al.
American Journal of Clinical Oncology|November 6, 2025
Real World Radiographic Response Rates and Preoperative Attrition in Patients With Non-Small Cell Lung Cancer (NSCLC) Treated With Neoadjuvant ChemoimmunotherapyCole Friedes, Michelle Iocolano, Nikhil Yegya-Raman, et al.
Pageof 12